細胞治療用原料の市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2025年～2030年

細胞治療原料市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の細胞治療原料市場規模は2030年までに125億9,000万米ドルに達すると予測されています。

同市場は2025～2030年にかけてCAGR 18.16％で成長すると予測されています。様々な細胞ベースの医薬品の研究開発への投資の増加や、様々な臨床研究のための多数の国々での政府投資の増加が、市場の成長に貢献すると予測されています。さらに、新興諸国におけるバイオ医薬品・バイオテクノロジー産業の開発が進んでいることも、予測期間における市場の成長をさらに後押ししています。

COVID-19パンデミックは細胞治療原料産業に大きな影響を与えました。ウイルスが世界的に蔓延する中、サプライチェーンの混乱、労働力不足、輸送制限などが、細胞治療製造に必要な重要原料の生産と流通に大きな課題をもたらしました。多くのサプライヤーは、成長因子、培養培地、バイオリアクターなどの必須成分の調達と納入の遅れに直面しました。その結果、細胞治療企業の生産が滞り、コストが増加しました。加えて、パンデミック（世界的大流行）時の医療用品に対する需要の高まりがリソースを圧迫し、価格変動につながりました。こうした課題にもかかわらず、細胞治療産業は新たな調達戦略や規制の変更に適応することで回復力を示し、サプライチェーンの多様化と不測の世界的危機への備えの重要性を強調しました。

さらに、細胞治療産業は、バイオファーマ企業による進歩や革新の著しい急増を目の当たりにすると予想されます。こうした進歩は、様々な疾患や病状を治療するための効果的な細胞ベースの治療に対する需要の高まりによってさらに推進されるであると考えられます。さらに、様々なバイオテクノロジー企業や製薬企業の拡大が、予測期間中の市場成長をさらに促進すると予想されます。

細胞療法製造の拡大の増加は、FDA承認の上昇とともに、原料市場に多くの機会を開いています。いくつかのメーカーは、細胞治療セグメントでの足跡を増やすためにそのような施設を開設しています。例えば、2023年6月、Bristol Myers Squibbは、マサチューセッツ州デベンズにある新しい細胞治療製造施設で商業生産を開始する承認を米国FDAから取得しました。同社の治療ポートフォリオを長期的に供給するために、デベンズの施設はBMSの世界の細胞治療生産インフラの重要な一部となっています。

しかし、コストと価格が市場の成長を抑制しています。細胞治療の生産に不可欠なこれらの材料は、入手や製造にコストがかかります。このコスト負担は、細胞ベースの治療法の開発と提供における費用を増加させ、経済的制約のために、より多くの人々へのアクセスを制限する可能性があります。品質と価格のバランスを取ることは、細胞療法を進歩させ、医療産業においてより広範な利用可能性と受容性を確保する上で重要な課題です。

細胞治療原料市場レポートハイライト

• 市場は製品別に、培地、血清、細胞培養サプリメント、抗体、試薬・緩衝液、その他に区分されます。細胞培養サプリメントセグメントは2024年に25.27%の最大市場シェアを占めました。
• 市場は最終用途に基づき、バイオ医薬品・製薬会社、CMO・CRO、その他に区分されます。2024年には、バイオ医薬品・製薬企業セグメントが53.54%の最大市場シェアを占めました。
• 北米は2024年に47.30%のシェアを占め、細胞治療原料産業を支配しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 産業分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 製品ビジネス分析

• 製品セグメントダッシュボード
• 細胞治療原料市場：製品変動分析
• 細胞治療原料市場規模と動向分析、製品別、2018～2030年
• 培地
  • 培地市場、2018～2030年
• 血清
  • 血清市場、2018～2030年
• 細胞培養サプリメント
  • 細胞培養サプリメント市場、2018～2030年
• 抗体
  • 抗体市場、2018～2030年
• 試薬・緩衝液
  • 試薬・緩衝剤市場、2018～2030年
• その他
  • その他市場、2018～2030年

第5章 最終用途ビジネス分析

• 細胞治療原料市場：最終用途変動分析
• バイオ医薬品と製薬会社
  • バイオ医薬品と製薬会社市場、2018～2030年
• CRO・CMO
  • CRO・CMO市場、2018～2030年
• その他
  • その他市場、2018～2030年

第6章 地域ビジネス分析

• 細胞治療原料市場シェア（地域別、2024年と2030年）
• 北米
  • 北米細胞治療原料市場、2018～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州の細胞治療原料市場、2018～2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋細胞治療原料市場、2018～2030年
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ラテンアメリカ細胞治療原料市場、2018～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ細胞療法原料市場、2018～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 企業分類
• 戦略マッピング
• Company Position Analysis, 2024
• 企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Actylis.
  • ACROBiosystems
  • STEMCELL Technologies
  • Grifols, SA
  • Charles River Laboratories
  • RoosterBio, Inc.
  • PromoCell GmbH
  • Danaher
  • Sartorius Stedim BIoTech

List of Tables

• Table 1 Global cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 2 Global cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 3 Global cell therapy raw materials market, by region, 2018 - 2030 (USD Million)
• Table 4 North America cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
• Table 5 North America cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 6 North America cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 7 U.S. cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 8 U.S. cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 9 Canada cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 10 Canada cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 11 Mexico cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 12 Mexico cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 13 Europe cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
• Table 14 Europe cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 15 Europe cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 16 UK cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 17 UK cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 18 Germany cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 19 Germany cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 20 France cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 21 France cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 22 Italy cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 23 Italy cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 24 Spain cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 25 Spain cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 26 Denmark cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 27 Denmark cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 28 Sweden cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 29 Sweden cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 30 Norway cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 31 Norway cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 32 Asia Pacific cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
• Table 33 Asia Pacific cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 34 Asia Pacific cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 35 Japan cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 36 Japan cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 37 China cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 38 China cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 39 India cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 40 India cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 41 Australia cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 42 Australia cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 43 South Korea cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 44 South Korea cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 45 Thailand cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 46 Thailand cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 47 Latin America cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
• Table 48 Latin America cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 49 Latin America cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 50 Brazil cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 51 Brazil cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 52 Argentina cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 53 Argentina cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 54 Middle East & Africa cell therapy raw materials market, by country, 2018 - 2030 (USD Million)
• Table 55 Middle East & Africa cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 56 Middle East & Africa cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 57 South Africa cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 58 South Africa cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 59 Saudi Arabia cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 60 Saudi Arabia cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 61 UAE cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 62 UAE cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 63 Kuwait cell therapy raw materials market, by product, 2018 - 2030 (USD Million)
• Table 64 Kuwait cell therapy raw materials market, by end Use, 2018 - 2030 (USD Million)
• Table 65 Key companies undertaking acquisitions
• Table 66 Key companies launching new products/services
• Table 67 Key companies undertaking collaborations and partnerships
• Table 68 Key companies undertaking other initiatives

List of Figures

• Fig. 1 Market research process
• Fig. 2 Cell therapy raw materials market segmentation
• Fig. 3 Data analysis models
• Fig. 4 Market formulation and validation
• Fig. 5 Data validating & publishing
• Fig. 6 Market research process
• Fig. 7 Information procurement
• Fig. 8 Primary research
• Fig. 9 Value-chain-based sizing & forecasting
• Fig. 10 QFD modelling for market share assessment
• Fig. 11 Market formulation & validation
• Fig. 12 Commodity flow analysis
• Fig. 13 Market snapshot
• Fig. 14 Segment snapshot
• Fig. 15 Segment snapshot
• Fig. 16 Competitive landscape snapshot
• Fig. 17 Market trends & outlook
• Fig. 18 Porter's five force analysis
• Fig. 19 SWOT analysis, by factor (Political, Economic, Social, Technological, and Legal)
• Fig. 20 Cell therapy raw materials market: product outlook key takeaways
• Fig. 21 Cell therapy raw materials market: product movement analysis
• Fig. 22 Media market, 2018 - 2030 (USD Million)
• Fig. 23 Sera market, 2018 - 2030 (USD Million)
• Fig. 24 Cell culture supplements market, 2018 - 2030 (USD Million)
• Fig. 25 Antibodies market, 2018 - 2030 (USD Million)
• Fig. 26 Reagents & buffers market, 2018 - 2030 (USD Million)
• Fig. 27 Others market, 2018 - 2030 (USD Million)
• Fig. 28 Cell therapy raw materials market: end Use outlook key takeaways
• Fig. 29 Cell therapy raw materials market: end Use movement analysis
• Fig. 30 Biopharmaceutical & pharmaceutical companies market, 2018 - 2030 (USD Million)
• Fig. 31 CROs & CMOs supplements market, 2018 - 2030 (USD Million)
• Fig. 32 Others supplements market, 2018 - 2030 (USD Million)
• Fig. 33 Cell therapy raw materials market revenue, by region, 2022 & 2030 (USD Million)
• Fig. 34 Regional marketplace: key takeaways
• Fig. 35 North America cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 US cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 US Key country dynamics
• Fig. 38 Canada cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Canada Key country dynamics
• Fig. 40 Mexico cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Mexico Key country dynamics
• Fig. 42 Europe cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 UK cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 UK Key country dynamics
• Fig. 45 Germany cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Germany Key country dynamics
• Fig. 47 France cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 France Key country dynamics
• Fig. 49 Spain cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Spain Key country dynamics
• Fig. 51 Italy cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Italy Key country dynamics
• Fig. 53 Denmark cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Denmark Key country dynamics
• Fig. 55 Sweden cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Sweden Key country dynamics
• Fig. 57 Norway cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Norway Key country dynamics
• Fig. 59 Asia Pacific cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Japan cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Japan Key country dynamics
• Fig. 62 China cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 China Key country dynamics
• Fig. 64 India cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 India Key country dynamics
• Fig. 66 Australia cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Australia Key country dynamics
• Fig. 68 South Korea cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 South Korea Key country dynamics
• Fig. 70 Thailand cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Thailand Key country dynamics
• Fig. 72 Latin America cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Brazil cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Brazil Key country dynamics
• Fig. 75 Argentina cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Argentina Key country dynamics
• Fig. 77 MEA cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 South Africa cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 South Africa Key country dynamics
• Fig. 80 Saudi Arabia cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Saudi Arabia Key country dynamics
• Fig. 82 UAE cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83 UAE Key country dynamics
• Fig. 84 Kuwait cell therapy raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Kuwait Key country dynamics
• Fig. 86 Market participant categorization
• Fig. 87 Strategic framework

Cell Therapy Raw Materials Market Growth & Trends:

The global cell therapy raw materials market size is anticipated to reach USD 12.59 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 18.16% from 2025 to 2030. The rising investments in the research and development of various cell-based drugs and the increasing number of government investments in numerous countries for various clinical studies are anticipated to contribute to the growth of the market. Moreover, the growing developments in the biopharmaceutical & biotechnology industry in developing countries are further fueling the growth of the market over the forecast period.

The COVID-19 pandemic had a significant impact on the cell therapy raw materials industry. As the virus spread globally, disruptions in supply chains, workforce shortages, and transportation restrictions posed significant challenges to the production and distribution of critical raw materials required for cell therapy manufacturing. Many suppliers faced delays in the sourcing and delivery of essential components, such as growth factors, culture media, and bioreactors. This resulted in production slowdowns and increased costs for cell therapy companies. In addition, the heightened demand for medical supplies during the pandemic strained resources and led to price fluctuations. Despite these challenges, the cellular therapy industry demonstrated resilience by adapting to new sourcing strategies and regulatory changes, emphasizing the importance of supply chain diversification and preparedness in the face of unforeseen global crises.

Moreover, the cell therapy industry is anticipated to witness a significant surge in advancements and innovations by biopharma companies. These advances would be further propelled by the growing demand for effective cell-based therapies to treat a range of diseases and medical conditions. Furthermore, the growing expansion of various biotechnology and pharmaceutical companies is further expected to propel the growth of the market over the forecast period.

The increasing expansion of cellular therapy manufacturing along with rising FDA approvals are opening numerous opportunities for the raw materials market. Several manufacturers are opening such facilities to increase their footprint in the cellular therapy field. For instance, in June 2023, Bristol Myers Squibb received approval from the U.S. FDA to start its commercial production at its new cell therapy production facility in Devens, Massachusetts. For the long-term supply of the company's therapy portfolio, the Devens site is a crucial part of BMS' growing worldwide cell therapy production infrastructure.

However, the cost and affordability restrain the growth of the market. These materials, vital for cell therapy production, are costly to obtain and manufacture. This cost burden increases the expenses in the development and provision of cell-based therapies, potentially limiting their accessibility to a broader population due to financial constraints. Balancing quality and affordability is an acute concern in advancing cell therapies and ensuring their broader availability and acceptance within the healthcare industry.

Cell Therapy Raw Materials Market Report Highlights:

• Based on product, the market is segmented into media, sera, cell culture supplements, antibodies, reagents & buffers, and others. The cell culture supplements segment held the largest market share of 25.27% in 2024.
• Based on the end use, the market is segmented into biopharmaceutical & pharmaceutical companies, CMOs & CROs, and others. The biopharmaceutical & pharmaceutical companies segment held the largest market share of 53.54% in 2024.
• North America dominated the cell therapy raw materials industry with a share of 47.30% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product
  • 1.2.2. End Use
• 1.3. Regional Scope
• 1.4. Estimates and Forecast Timeline
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Primary Research
• 1.7. Information or Data Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Market Model
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Secondary Sources
• 1.11. List of Abbreviations
• 1.12. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising demand for cell therapies
    • 3.2.1.2. Advancements in research and development for cell-based therapies
    • 3.2.1.3. Technological Innovation
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost associated with the production and procurement of raw materials
    • 3.2.2.2. Stringent regulations associated with cell therapies
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Cell Therapy Raw Materials Market: Product Movement Analysis
• 4.3. Cell Therapy Raw Materials Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
• 4.4. Media
  • 4.4.1. Media Market, 2018 - 2030 (USD Million)
• 4.5. Sera
  • 4.5.1. Sera Market, 2018 - 2030 (USD Million)
• 4.6. Cell Culture Supplements
  • 4.6.1. Cell Culture Supplements Market, 2018 - 2030 (USD Million)
• 4.7. Antibodies
  • 4.7.1. Antibodies Market, 2018 - 2030 (USD Million)
• 4.8. Reagents & Buffers
  • 4.8.1. Reagents & Buffers Market, 2018 - 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. End Use Business Analysis

• 5.1. Cell Therapy Raw Materials Market: End Use Movement Analysis
• 5.2. Biopharmaceutical & Pharmaceutical Companies
  • 5.2.1. Biopharmaceutical & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
• 5.3. CROs & CMOs
  • 5.3.1. CROs & CMOs Market, 2018 - 2030 (USD Million)
• 5.4. Others
  • 5.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

• 6.1. Cell Therapy Raw Materials Market Share By Region, 2024 & 2030
• 6.2. North America
  • 6.2.1. North America Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. Key Country Dynamics
    • 6.2.2.2. Competitive Scenario
    • 6.2.2.3. Regulatory Framework
    • 6.2.2.4. U.S. Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Key Country Dynamics
    • 6.2.3.2. Competitive Scenario
    • 6.2.3.3. Regulatory Framework
    • 6.2.3.4. Canada Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.2.4. Mexico
    • 6.2.4.1. Key Country Dynamics
    • 6.2.4.2. Competitive Scenario
    • 6.2.4.3. Regulatory Framework
    • 6.2.4.4. Mexico Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. Key Country Dynamics
    • 6.3.2.2. Competitive Scenario
    • 6.3.2.3. Regulatory Framework
    • 6.3.2.4. UK Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Competitive Scenario
    • 6.3.3.3. Regulatory Framework
    • 6.3.3.4. Germany Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.3.4. France
    • 6.3.4.1. Key Country Dynamics
    • 6.3.4.2. Competitive Scenario
    • 6.3.4.3. Regulatory Framework
    • 6.3.4.4. France Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.3.5. Italy
    • 6.3.5.1. Key Country Dynamics
    • 6.3.5.2. Competitive Scenario
    • 6.3.5.3. Regulatory Framework
    • 6.3.5.4. Italy Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.3.6. Spain
    • 6.3.6.1. Key Country Dynamics
    • 6.3.6.2. Competitive Scenario
    • 6.3.6.3. Regulatory Framework
    • 6.3.6.4. Spain Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.3.7. Denmark
    • 6.3.7.1. Key Country Dynamics
    • 6.3.7.2. Competitive Scenario
    • 6.3.7.3. Regulatory Framework
    • 6.3.7.4. Denmark Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1. Key Country Dynamics
    • 6.3.8.2. Competitive Scenario
    • 6.3.8.3. Regulatory Framework
    • 6.3.8.4. Sweden Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.3.9. Norway
    • 6.3.9.1. Key Country Dynamics
    • 6.3.9.2. Competitive Scenario
    • 6.3.9.3. Regulatory Framework
    • 6.3.9.4. Norway Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.4.2. Japan
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. Japan Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.4.3. China
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. China Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.4.4. India
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Competitive Scenario
    • 6.4.4.3. Regulatory Framework
    • 6.4.4.4. India Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.4.5. Australia
    • 6.4.5.1. Key Country Dynamics
    • 6.4.5.2. Competitive Scenario
    • 6.4.5.3. Regulatory Framework
    • 6.4.5.4. Australia Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.4.6. Thailand
    • 6.4.6.1. Key Country Dynamics
    • 6.4.6.2. Competitive Scenario
    • 6.4.6.3. Regulatory Framework
    • 6.4.6.4. Thailand Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.4.7. South Korea
    • 6.4.7.1. Key Country Dynamics
    • 6.4.7.2. Competitive Scenario
    • 6.4.7.3. Regulatory Framework
    • 6.4.7.4. South Korea Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Brazil Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.5.3. Argentina
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Argentina Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
• 6.6. MEA
  • 6.6.1. MEA Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. South Africa Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Saudi Arabia Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.6.4. UAE
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. UAE Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)
  • 6.6.5. Kuwait
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Kuwait Cell Therapy Raw Materials Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Strategy Mapping
• 7.3. Company Position Analysis, 2024
• 7.4. Company Profiles
  • 7.4.1. Thermo Fisher Scientific Inc.
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Merck KGaA
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. Actylis.
    • 7.4.3.1. Overview
    • 7.4.3.2. Product Benchmarking
    • 7.4.3.3. Strategic Initiatives
  • 7.4.4. ACROBiosystems
    • 7.4.4.1. Overview
    • 7.4.4.2. Product Benchmarking
    • 7.4.4.3. Strategic Initiatives
  • 7.4.5. STEMCELL Technologies
    • 7.4.5.1. Overview
    • 7.4.5.2. Product Benchmarking
    • 7.4.5.3. Strategic Initiatives
  • 7.4.6. Grifols, S.A.
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. Charles River Laboratories
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. RoosterBio, Inc.
    • 7.4.8.1. Overview
    • 7.4.8.2. Product Benchmarking
    • 7.4.8.3. Strategic Initiatives
  • 7.4.9. PromoCell GmbH
    • 7.4.9.1. Overview
    • 7.4.9.2. Product Benchmarking
    • 7.4.9.3. Strategic Initiatives
  • 7.4.10. Danaher
    • 7.4.10.1. Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Strategic Initiatives
  • 7.4.11. Sartorius Stedim Biotech
    • 7.4.11.1. Overview
    • 7.4.11.2. Financial Performance
    • 7.4.11.3. Product Benchmarking
    • 7.4.11.4. Strategic Initiatives